V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20158541 | 20060729 | 1.75 | 106.55 | Curative (C) | 2018-11-30 | 2018-12-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101438621 |
| 20158543 | 20060730 | 1.6 | 58 | Adjuvant (A) | null | 2019-09-30 | CAPECITABINE + GEMCITABINE | N | null | CAPECITABINE + GEMCITABINE | 100010380 |
| 20158549 | 20060731 | 1.62 | 57.6 | Neo-adjuvant (N) | 2018-07-30 | 2018-07-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100951663 |
| 20158552 | 20060732 | 1.73 | 110 | Curative (C) | 2019-03-03 | 2019-03-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100934551 |
| 20158555 | 20060733 | null | null | Palliative (P) | 2017-05-27 | 2017-06-06 | ECX | N | N | ECX | 101822851 |
| 20158556 | 20060734 | 1.72 | 82.2 | Palliative (P) | 2016-04-25 | 2016-05-06 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101726153 |
| 20158559 | 20060735 | 1.71 | 63 | Palliative (P) | 2016-01-29 | 2016-02-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101689101 |
| 20158561 | 20060736 | 1.52 | 81 | Palliative (P) | 2017-10-07 | 2017-10-28 | ECX | N | N | ECX | 101075070 |
| 20158562 | 20060737 | 1.73 | 86.6 | Adjuvant (A) | 2016-07-24 | 2016-08-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100456736 |
| 20158563 | 20060738 | 1.65 | 52.8 | Neo-adjuvant (N) | 2019-02-20 | 2019-03-03 | ECX | N | N | ECX | 100957827 |
| 20158564 | 20060739 | 1.63 | 96.3 | Palliative (P) | null | 2018-06-10 | Gemcitabine + Capecitabine | null | N | ECX | 101340367 |
| 20158566 | 20060740 | 1.64 | 51.5 | Palliative (P) | 2017-02-25 | 2017-03-04 | ECX | 2 | N | ECX | 100551742 |
| 20158567 | 20060741 | 1.67 | 65 | Neo-adjuvant (N) | 2016-11-21 | 2016-12-22 | ECX | N | N | ECX | 101307040 |
| 20158569 | 20060742 | 1.74 | 132 | null | 2016-12-25 | 2016-12-26 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101596442 |
| 20158570 | 20060743 | 1.84 | 77.5 | Adjuvant (A) | 2018-02-11 | 2018-03-06 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100014963 |
| 20158571 | 20060744 | 1.84 | 65.6 | Palliative (P) | 2016-12-27 | 2017-01-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101425012 |
| 20158572 | 20060745 | 1.7 | 85.8 | Neo-adjuvant (N) | 2018-08-27 | 2018-09-13 | ECX | N | N | ECX | 100938817 |
| 20158573 | 20060746 | 1.55 | 66.2 | Palliative (P) | 2019-03-21 | 2019-04-04 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101662428 |
| 20158574 | 20060747 | 1.7 | 76.8 | Neo-adjuvant (N) | 2016-06-06 | 2016-06-14 | ECX | N | N | ECX | 101255481 |
| 20158575 | 20060748 | 1.67 | 76 | Palliative (P) | 2016-02-03 | 2016-02-05 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100359331 |
| 20158577 | 20060749 | 1.52 | 42.8 | Palliative (P) | 2019-01-17 | 2019-01-19 | ECX | N | N | ECX | 101246607 |
| 20158580 | 20060750 | null | null | Adjuvant (A) | 2019-11-28 | 2019-12-16 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101184711 |
| 20158584 | 20060751 | 1.68 | 87.9 | Neo-adjuvant (N) | 2018-04-29 | 2018-05-07 | ECX | N | N | ECX | 101149928 |
| 20158585 | 20060752 | 1.82 | 82 | Palliative (P) | 2017-03-08 | 2017-03-24 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100218212 |
| 20158587 | 20060753 | 1.7 | 77.8 | Adjuvant (A) | 2016-12-12 | 2016-12-26 | Gemcitabine + Capecitabine | 2 | null | CAPECITABINE + GEMCITABINE | 100488836 |
| 20158588 | 20060754 | 1.69 | 70.4 | Adjuvant (A) | 2017-12-14 | 2018-01-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100986328 |
| 20158589 | 20060755 | 1.64 | 58.4 | Neo-adjuvant (N) | 2018-12-27 | 2019-01-17 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100977690 |
| 20158592 | 20060756 | 1.86 | 87.8 | Adjuvant (A) | 2019-09-22 | 2019-09-22 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101086302 |
| 20158593 | 20060757 | 1.67 | 69 | Palliative (P) | 2017-02-20 | 2017-03-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101062725 |
| 20158595 | 20060758 | 1.6 | 84.9 | Adjuvant (A) | 2018-10-02 | 2018-10-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100346917 |
| 20158596 | 20060759 | 1.57 | 74.4 | Palliative (P) | null | 2016-01-24 | ECX | N | N | ECX | 101449246 |
| 20158597 | 20060760 | 1.73 | 87.5 | Adjuvant (A) | 2017-09-29 | 2017-10-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101339860 |
| 20158598 | 20060761 | 1.65 | 83.6 | Neo-adjuvant (N) | 2019-01-28 | 2019-02-04 | ECX | N | null | ECX | 100585704 |
| 20158600 | 20060762 | 1.84 | 78 | Neo-adjuvant (N) | 2017-08-15 | 2017-09-07 | ECX | N | N | ECX | 101399745 |
| 20158604 | 20060763 | 1.78 | 60 | Neo-adjuvant (N) | 2018-07-04 | 2018-07-23 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101722814 |
| 20158605 | 20060764 | 1.76 | 60.6 | Curative (C) | 2019-01-16 | 2019-02-10 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101428192 |
| 20158606 | 20060765 | 1.62 | 52.9 | Palliative (P) | 2017-07-10 | 2017-07-13 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100814739 |
| 20158608 | 20060766 | 1.68 | 71.2 | Curative (C) | 2018-11-26 | 2018-12-02 | ECX | 02 | null | ECX | 101451008 |
| 20158609 | 20060767 | 1.77 | 78 | Curative (C) | null | 2018-11-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100471382 |
| 20158611 | 20060768 | 1.57 | 61.1 | Neo-adjuvant (N) | 2019-12-20 | 2019-12-20 | ECX | 2 | N | ECX | 101239786 |
| 20158613 | 20060769 | 1.7 | 79 | Palliative (P) | 2019-12-18 | 2019-12-24 | ECX | N | N | ECX | 101788197 |
| 20158616 | 20060770 | 1.57 | 44.4 | 03 | 2017-07-13 | 2017-09-08 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100481562 |
| 20158618 | 20060771 | 1.6 | 57.2 | null | null | 2019-08-03 | ECX | N | N | ECX | 101534712 |
| 20158619 | 20060772 | 1.69 | 63.3 | Adjuvant (A) | 2017-06-11 | 2017-06-26 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101022858 |
| 20158620 | 20060773 | 1.66 | 71.7 | Palliative (P) | 2016-09-24 | 2016-10-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100187864 |
| 20158623 | 20060774 | 1.72 | 77.5 | Neo-adjuvant (N) | 2017-01-21 | 2017-02-03 | ECX | N | N | ECX | 101598435 |
| 20158624 | 20060775 | 1.73 | 83.4 | Palliative (P) | 2018-03-07 | 2018-03-30 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101348183 |
| 20158633 | 20060776 | 1.74 | 62 | Palliative (P) | 2017-11-09 | 2017-11-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101662546 |
| 20158634 | 20060777 | 1.6 | 47.75 | Neo-adjuvant (N) | 2017-02-14 | 2017-02-14 | ECX | null | N | ECX | 101731919 |
| 20158635 | 20060778 | 1.75 | 89.35 | Adjuvant (A) | 2017-04-28 | 2017-05-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101095503 |